Assertio Holdings | DEPO - Operating Profit

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $-3.05M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Cara Therapeutics USD -2.39M 3.49M Mar/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 5.59B 1.81B Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -34.34M 15.43M Sep/2024
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.65B 3.99B Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025